Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Onno W. Akkerman"'
Autor:
Tjip S. van der Werf, Onno W. Akkerman
Publikováno v:
Essential Tuberculosis ISBN: 9783030667054
Increasing complexity of tuberculosis (TB) is one of the causes that TB is still the leading cause of death by an infectious disease. Among the complicating factors are increasing drug resistance and comorbidities. Patient-centred care, and even more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11e1d3d7d4a370ec3b8345de1a7aa2d3
https://doi.org/10.1007/978-3-030-66703-0_20
https://doi.org/10.1007/978-3-030-66703-0_20
Publikováno v:
International Journal of Tuberculosis and Lung Disease, 25(6), 419-420. International Union against Tubercul. and Lung Dis.
The International Journal of Tuberculosis and Lung Disease
The International Journal of Tuberculosis and Lung Disease
SUMMARY BACKGROUND: There are no data comparing the 6–9 month oral three-drug Nix regimen (bedaquiline, pretomanid and linezolid [BPaL]) to conventional regimens containing bedaquiline (B, BDQ) and linezolid (L, LZD). METHODS: Six-month post end-of
Autor:
Onno W. Akkerman, Mireille A. Wessels, Samiksha Ghimire, Daan J Touw, Jan-Willem C. Alffenaar, Erwin M Jongedijk, Simone H J van den Elsen, Mathieu S. Bolhuis, Tjip S. van der Werf
Publikováno v:
European Respiratory Journal, 56(4):2000803. EUROPEAN RESPIRATORY SOC JOURNALS LTD
The persisting worldwide burden of tuberculosis (TB) is worrisome. In 2018, an estimated 10 million individuals developed TB and 1.45 million deceased [1]. The increase in drug resistance is an important point of concern. Resistance can be acquired b
Publikováno v:
New England Journal of Medicine, 382(24), 2376-2377. MASSACHUSETTS MEDICAL SOC
BACKGROUND Patients with highly drug-resistant forms of tuberculosis have limited treatment options and historically have had poor outcomes. METHODS In an open-label, single-group study in which follow-up is ongoing at three South African sites, we i
Autor:
Richard van Altena, Jan-Willem C. Alffenaar, Tjip S. van der Werf, Onno W. Akkerman, Sander P. van Rijn, Richard M. Anthony, Jos G. W. Kosterink, Wiel C M de Lange, Marlanka A Zuur, Bob Wilffert
Publikováno v:
Antimicrobial Agents and Chemotherapy, 63(2):ARTN e01489-18. AMER SOC MICROBIOLOGY
Multi-and extensively drug-resistant tuberculosis (M/XDR-TB) has become an increasing threat not only in countries where the TB burden is high but also in affluent regions, due to increased international travel and globalization. Carbapenems are earm
Publikováno v:
Tuberculosis, 308-326
STARTPAGE=308;ENDPAGE=326;TITLE=Tuberculosis
STARTPAGE=308;ENDPAGE=326;TITLE=Tuberculosis
TB treatment is long and often complicated by adverse reactions. Baseline assessment can reduce the likelihood of adverse reactions, especially DILI. Regular monitoring can ensure treatment efficacy and prevent serious complications. A slow response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f499ca14d4b329bfa9724dcd5857bd
https://research.rug.nl/en/publications/953ceb11-e8be-40ed-99ca-7f4b17d1ebaf
https://research.rug.nl/en/publications/953ceb11-e8be-40ed-99ca-7f4b17d1ebaf
Autor:
Shashikant Srivastava, Marieke G G Sturkenboom, Mathieu S. Bolhuis, Samiksha Ghimire, Tawanda Gumbo, Onno W. Akkerman, Jan-Willem C. Alffenaar
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 67(suppl_3)
Linezolid has been successfully used for treatment of multidrug-resistant tuberculosis (MDR-TB). However, dose- and duration-related toxicity limit its use. Here, our aim was to search relevant pharmacokinetics (PK)/pharmacodynamics (PD) literature t
Autor:
Johanna Kuhlin, Judith Bruchfeld, Onno W. Akkerman, Ioana Margineanu, Simone H J van den Elsen, Samiksha Ghimire, Remco A. Koster, Jan-Willem C. Alffenaar, Noviana Simbar, Erwin M Jongedijk, Daan J Touw, Marieke G G Sturkenboom
Publikováno v:
Clin Mass Spectrom
Clinical Mass Spectrometry, 14(Part A), 34-45. Elsevier
Clinical Mass Spectrometry, 14(Part A), 34-45. Elsevier
Therapeutic drug monitoring (TDM) uses drug concentrations, primarily from plasma, to optimize drug dosing. Optimisation of drug dosing may improve treatment outcomes, reduce toxicity and reduce the risk of acquired drug resistance. The aim of this n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4788544fe044ad6aaa762c3f94089626
https://europepmc.org/articles/PMC8653513/
https://europepmc.org/articles/PMC8653513/
Autor:
Fabrizio Palmieri, Aurora Jazmín Roby Arias, Alena Skrahina, Gina Gualano, Giovanni Sotgiu, Dante Vargas Vasquez, Eduardo Henrique Bonini, Marina Tadolini, Gerard de Vries, Saverio De Lorenzo, Jose A. Caminero, Pietro Viggiani, Marcos Abdo Arbex, Valentina Alarcon Guizado, Apostolos Papavasileiou, Lorena Collahuazo López, Simon Tiberi, Simone Dore, Andrea Piana, Anna Scardigli, Vera Auchynka, Marie-Christine Payen, Antonio Spanevello, Felix Antonio Chong Marin, Alena Aleksa, Edith Alarcon Arrascue, Janina Artsukevich, Heinke Kunst, Alberto Matteelli, Onno W. Akkerman, Giorgia Sulis, Alimuddin Zumla, Giovanni Battista Migliori, Lia D'Ambrosio, Ivan Solovic, Jan-Willem C. Alffenaar, Mina Gaga, Charalampos Moschos, Veronica White, Rosella Centis
Publikováno v:
European Respiratory Journal, 47(6), 1758-1766. EUROPEAN RESPIRATORY SOC JOURNALS LTD
No large study to date has ever evaluated the effectiveness, safety and tolerability of imipenem/clavulanateversusmeropenem/clavulanate to treat multidrug- and extensively drug-resistant tuberculosis (MDR- and XDR-TB). The aim of this observational s
Autor:
Jan-Willem C. Alffenaar, Onno W. Akkerman, Ivan S. Pradipta, N. van't Boveneind-Vrubleuskaya, Eelko Hak
Publikováno v:
Clinical Microbiology and Infection, 25(6), 761.e1-761.e7. ELSEVIER SCI LTD
ObjectivesWe evaluated treatment outcomes and predictors for poor treatment outcomes for tuberculosis (TB) among native- and foreign-born patients with drug-susceptible TB (DSTB) in the Netherlands.MethodsThis retrospective cohort study included adul